Skip to content

Released Nov 1, 2017, after the close

10-Q filed Nov 1, 2017, 32 days after period end · 0001144204-17-055501

Q3 2017 · 10-Q
Revenue$2.66Mno prior Q3 2016 on file+12.7% vs Q2 2017
Net Income-$12.27MN/M vs Q3 2016N/M vs Q2 2017
EPS Diluted-$710.00N/M vs Q3 2016N/M vs Q2 2017
Operating Income-$12,450,180N/M
Operating Cash Flowderived-$10,957,614N/M
Free Cash Flowderived-$11,460,729N/M
Margins · derived
Operating margin-468.1%
Net margin-461.4%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2017Q3 2016Q3 2015Q3 2014
Revenue$2.66M———
Net Income-$12.27M-$11.57M-$6.62M-$11.02M
EPS Diluted-$710.00-$0.67-$0.38-$1.33

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR